<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of PharmTech Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPTR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2249-3387</issn>
      <publisher>
        <publisher-name>undefined</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">AJPTR56010</article-id>
      <title-group>
        <article-title>Design, Synthesis, Characterization and Biological Evaluation of some novel Heterocyclic derivatives as Anti-Tubercular agents</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Suresh</surname>
            <given-names>Ayyadurai Jerad</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Surya</surname>
            <given-names>Parakkot Ramakrishnan</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Velankani</surname>
            <given-names>Antonyraj</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">Department of pharmaceutical chemistry, College of Pharmacy, Madras Medical College, Chennai-600003, India</aff>
      <pub-date pub-type="epub" iso-8601-date="2015-12-01">
        <month>12</month>
        <day>01</day>
        <year>2015</year>
      </pub-date>
      <volume>5</volume>
      <issue>6</issue>
      <abstract>
        <p>Tuberculosis is a serious threat to public health throughout the world. Schiff bases are compounds carrying the imine or azomethine (–C=N–) functional group. Recent studies report that benzimidazole based Schiff bases possess antibacterial, antimicrobial, anti-tubercular, and anti-inflammatory activities. 1,2 Further it has been known that fluoroaniline moiety can have profound and unexpected results in biological activity 19. A series of benzimidazole and fluroaniline based Schiff bases were designed and docked against crucial mtb enzyme target Glutamine synthetase1. The molecules with good docking-score and multiple interactions were chosen for synthesis. Compounds (BE1, BE2, FA-1, FA-2, and FA-3) were synthesized by reflux condensation reaction with good yield. The newly synthesized compounds were characterized by spectral methods and evaluated for anti- mycobacterial activity against tuberculosis H37RV strain. Anti-tubercular activity was carried out by using Microplate Alamar Blue Assay (MABA) method. The experimental results revealed that Compounds (BE1&amp; BE2) showed promising anti-tubercular activity with an MIC below 0.8 mcg/mL while (FA-1, FA-2, and FA-3) showed moderate anti tubercular activity with an MIC below 6.25 and 12.5 mcg/mL. Key words: Benzimidazole, Schiff base, Fluoroaniline, Docking, Anti-tubercular.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Benzimidazole</kwd>
        <kwd>Schiff base</kwd>
        <kwd>Fluoroaniline</kwd>
        <kwd>Docking</kwd>
        <kwd>Anti-tubercular.</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
